Activity of natural and synthetic naphthoquinones against Toxoplasma gondii, in vitro and in murine models of infection

The effect of 14 natural and synthetic naphthoquinones in the replication of Toxoplasma gondii was evaluated. In vitro studies were accomplished in cultures of 2C4 fibroblasts infected with RH- strain. Enzyme-linked immunosorbent assay was used to quantify parasite growth. For the studies in vivo, m...

Full description

Bibliographic Details
Main Authors: Ferreira R.A., Oliveira A.B., Gualberto S.A., Vitor R.W.A.
Format: Article
Language:English
Published: EDP Sciences 2002-09-01
Series:Parasite
Subjects:
Online Access:http://dx.doi.org/10.1051/parasite/2002093261
_version_ 1827614598628376576
author Ferreira R.A.
Oliveira A.B.
Gualberto S.A.
Vitor R.W.A.
author_facet Ferreira R.A.
Oliveira A.B.
Gualberto S.A.
Vitor R.W.A.
author_sort Ferreira R.A.
collection DOAJ
description The effect of 14 natural and synthetic naphthoquinones in the replication of Toxoplasma gondii was evaluated. In vitro studies were accomplished in cultures of 2C4 fibroblasts infected with RH- strain. Enzyme-linked immunosorbent assay was used to quantify parasite growth. For the studies in vivo, mice were infected with tachyzoites of the RH strain or cysts of the T. gondii EGS strain. In vitro, seven naphthoquinones demonstrated significant inhibition of intracellular T. gondii growth at concentrations of 1 and 5 μg/ml. Only three compounds were significantly protective when tested in animals: 2-hydroxy-3'-(3'-pentenyl)-l ,4-naphthoquinone (PHNQ4), 2-hydroxy-3-(l'-vinylphenyl)-l,4-naphthoquinone (PHNQ5) and 2- hydroxy-3-(l'-propen-3'-phenyl)-1,4- naphthoquinone (PHNQ6). In animals infected with the EGS strain and treated with PHNQ4 (50 mg/kg/day orally), a 7-day prolongation of the time to death was observed. Treatment with 100 mg/kg/day orally or 50 mg/kg/day i.p. of PHNQ5 resulted in a 5-day and 16-day prolongation of the time to death, respectively. Treatment with 50 mg/kg/day orally or 50 mg/kg/day i.p. of PHNQ6 resulted in a 4-day prolongation of the time to death or up to 30 days after treatment, respectively. Our results suggest that the naphthoquinones may be important therapeutic agents for the treatment of toxoplasmosis.
first_indexed 2024-03-09T08:58:06Z
format Article
id doaj.art-629306b9f6fa4570a627777522d47ae5
institution Directory Open Access Journal
issn 1252-607X
1776-1042
language English
last_indexed 2024-03-09T08:58:06Z
publishDate 2002-09-01
publisher EDP Sciences
record_format Article
series Parasite
spelling doaj.art-629306b9f6fa4570a627777522d47ae52023-12-02T12:36:36ZengEDP SciencesParasite1252-607X1776-10422002-09-019326126910.1051/parasite/2002093261parasite2002093p261Activity of natural and synthetic naphthoquinones against Toxoplasma gondii, in vitro and in murine models of infectionFerreira R.A.Oliveira A.B.Gualberto S.A.Vitor R.W.A.The effect of 14 natural and synthetic naphthoquinones in the replication of Toxoplasma gondii was evaluated. In vitro studies were accomplished in cultures of 2C4 fibroblasts infected with RH- strain. Enzyme-linked immunosorbent assay was used to quantify parasite growth. For the studies in vivo, mice were infected with tachyzoites of the RH strain or cysts of the T. gondii EGS strain. In vitro, seven naphthoquinones demonstrated significant inhibition of intracellular T. gondii growth at concentrations of 1 and 5 μg/ml. Only three compounds were significantly protective when tested in animals: 2-hydroxy-3'-(3'-pentenyl)-l ,4-naphthoquinone (PHNQ4), 2-hydroxy-3-(l'-vinylphenyl)-l,4-naphthoquinone (PHNQ5) and 2- hydroxy-3-(l'-propen-3'-phenyl)-1,4- naphthoquinone (PHNQ6). In animals infected with the EGS strain and treated with PHNQ4 (50 mg/kg/day orally), a 7-day prolongation of the time to death was observed. Treatment with 100 mg/kg/day orally or 50 mg/kg/day i.p. of PHNQ5 resulted in a 5-day and 16-day prolongation of the time to death, respectively. Treatment with 50 mg/kg/day orally or 50 mg/kg/day i.p. of PHNQ6 resulted in a 4-day prolongation of the time to death or up to 30 days after treatment, respectively. Our results suggest that the naphthoquinones may be important therapeutic agents for the treatment of toxoplasmosis.http://dx.doi.org/10.1051/parasite/2002093261naphthoquinonesToxoplasma gondiistrainin vitromurine models
spellingShingle Ferreira R.A.
Oliveira A.B.
Gualberto S.A.
Vitor R.W.A.
Activity of natural and synthetic naphthoquinones against Toxoplasma gondii, in vitro and in murine models of infection
Parasite
naphthoquinones
Toxoplasma gondii
strain
in vitro
murine models
title Activity of natural and synthetic naphthoquinones against Toxoplasma gondii, in vitro and in murine models of infection
title_full Activity of natural and synthetic naphthoquinones against Toxoplasma gondii, in vitro and in murine models of infection
title_fullStr Activity of natural and synthetic naphthoquinones against Toxoplasma gondii, in vitro and in murine models of infection
title_full_unstemmed Activity of natural and synthetic naphthoquinones against Toxoplasma gondii, in vitro and in murine models of infection
title_short Activity of natural and synthetic naphthoquinones against Toxoplasma gondii, in vitro and in murine models of infection
title_sort activity of natural and synthetic naphthoquinones against toxoplasma gondii in vitro and in murine models of infection
topic naphthoquinones
Toxoplasma gondii
strain
in vitro
murine models
url http://dx.doi.org/10.1051/parasite/2002093261
work_keys_str_mv AT ferreirara activityofnaturalandsyntheticnaphthoquinonesagainsttoxoplasmagondiiinvitroandinmurinemodelsofinfection
AT oliveiraab activityofnaturalandsyntheticnaphthoquinonesagainsttoxoplasmagondiiinvitroandinmurinemodelsofinfection
AT gualbertosa activityofnaturalandsyntheticnaphthoquinonesagainsttoxoplasmagondiiinvitroandinmurinemodelsofinfection
AT vitorrwa activityofnaturalandsyntheticnaphthoquinonesagainsttoxoplasmagondiiinvitroandinmurinemodelsofinfection